John B Rhodes - Net Worth and Insider Trading

John B Rhodes Net Worth

The estimated net worth of John B Rhodes is at least $0 dollars as of 2024-05-27. John B Rhodes is the Director of Tonix Pharmaceuticals Holding Corp and owns about 1 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in John B Rhodes's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John B Rhodes has not made any transactions after 2018-06-01 and currently still holds the listed stock(s).

Transaction Summary of John B Rhodes

To

John B Rhodes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John B Rhodes owns 2 companies in total, including Tonix Pharmaceuticals Holding Corp (TNXP) , and Dewey Electronics Corp (DEWY) .

Click here to see the complete history of John B Rhodes’s form 4 insider trades.

Insider Ownership Summary of John B Rhodes

Ticker Comapny Transaction Date Type of Owner
TNXP Tonix Pharmaceuticals Holding Corp 2018-06-01 director
DEWY Dewey Electronics Corp 2005-12-07 director

John B Rhodes Latest Holdings Summary

John B Rhodes currently owns a total of 1 stock. John B Rhodes owns 1 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of June 1, 2018, with a value of $0.

Latest Holdings of John B Rhodes

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TNXP Tonix Pharmaceuticals Holding Corp 2018-06-01 1 0.18 0

Holding Weightings of John B Rhodes


John B Rhodes Form 4 Trading Tracker

According to the SEC Form 4 filings, John B Rhodes has made a total of 0 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 0 shares on June 1, 2018, which cost John B Rhodes around $24,975.

Insider Trading History of John B Rhodes

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John B Rhodes Trading Performance

GuruFocus tracks the stock performance after each of John B Rhodes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John B Rhodes is -50.39%. GuruFocus also compares John B Rhodes's trading performance to market benchmark return within the same time period. The performance of stocks bought by John B Rhodes within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John B Rhodes's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John B Rhodes

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 2.98
Relative Return to S&P 500(%) 2.34

John B Rhodes Ownership Network

Ownership Network List of John B Rhodes

No Data

Ownership Network Relation of John B Rhodes


John B Rhodes Owned Company Details

What does Tonix Pharmaceuticals Holding Corp do?

Who are the key executives at Tonix Pharmaceuticals Holding Corp?

John B Rhodes is the director of Tonix Pharmaceuticals Holding Corp. Other key executives at Tonix Pharmaceuticals Holding Corp include director & 10 percent owner & Chief Executive Officer Seth Lederman , Chief Medical Officer Gregory M Sullivan , and Chief Administrative Officer Jessica Edgar Morris .

Tonix Pharmaceuticals Holding Corp (TNXP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Tonix Pharmaceuticals Holding Corp (TNXP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tonix Pharmaceuticals Holding Corp Insider Transactions

No Available Data

John B Rhodes Mailing Address

Above is the net worth, insider trading, and ownership report for John B Rhodes. You might contact John B Rhodes via mailing address: 74 Fifth Avenue, New York Ny 10011.

Discussions on John B Rhodes

No discussions yet.